Arab Finance: The board of directors of Sabaa International for Pharmaceutical and Chemical Industry (SIPC) has agreed to cut the nominal value of the company’s stock to EGP 0.20 from EGP 2, according to a disclosure filed to the Egyptian Exchange (EGX) on August 10th.
Accordingly, the number of the company’s shares will be 500 million at a nominal value of EGP 0.20, and the issued and paid-up capital will remain unchanged at EGP 100 million.
Saba International is an Egypt-based company operating in the pharmaceutical sector, with a generic product portfolio that includes products focused on different therapeutic categories.